Research Topics
| S V KaneSummaryAffiliation: University of Chicago Country: USA Publications
| Collaborators
|
Detail Information
Publications
Systematic review: adherence issues in the treatment of ulcerative colitisS V Kane
Section of Gastroenterology, Department of Medicine, The University of Chicago, Chicago, IL, USA
Aliment Pharmacol Ther 23:577-85. 2006..It is a combination of understanding patient behaviour, recognizing signs of non-adherent behaviour and utilizing management strategies to change behaviour that will improve patient outcomes...
Gender issues in inflammatory bowel diseaseSunanda Kane
Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA
Womens Health (Lond Engl) 1:401-7. 2005..Healthcare providers, regardless of their primary focus, should be aware of these differences and be familiar with general information specific to women...
Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's diseaseSunanda Kane
Department of Medicine, University of Chicago, Chicago, IL 60637, USA
Inflamm Bowel Dis 10:652-4. 2004..We herein report a patient who developed acute sinusoidal obstruction syndrome after 14 months of successful thioguanine treatment. This is the first report of such a complication in an adult treated with 6-TG for active Crohn's disease...
Inflammatory bowel disease in pregnancySunanda Kane
Division of Gastroenterology, Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA
Gastroenterol Clin North Am 32:323-40. 2003..Most medications for IBD are safe during pregnancy and breastfeeding, with notable exceptions. Active disease is usually more deleterious than maintaining medical therapy...
Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remissionSunanda V Kane
University of Chicago, Chicago IL 60637, USA
J Clin Gastroenterol 39:32-5. 2005..To study the association between tobacco exposure and postoperative clinical recurrence in Crohn's disease patients and quantify the time to clinical relapse following surgical resection...
Medication nonadherence and the outcomes of patients with quiescent ulcerative colitisSunanda Kane
Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA
Am J Med 114:39-43. 2003..We conducted a prospective study to determine the effects of nonadherence with mesalamine among patients with quiescent ulcerative colitis...
The effectiveness of budesonide therapy for Crohn's diseaseS V Kane
Section of Digestive Deseases, University of Chicago School of Medicine, Chicago, Ill 60637, USA
Aliment Pharmacol Ther 16:1509-17. 2002..Trials had to report on the effectiveness of treatment (defined as decreasing or maintaining Crohn's Disease Activity Index, CDAI, scores < or = 150) or adverse events...
Thalidomide as "salvage" therapy for patients with delayed hypersensitivity response to infliximab: a case seriesSunanda Kane
Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA
J Clin Gastroenterol 35:149-50. 2002..Thalidomide appears to be a safe and effective alternative for short-term healing in patients who develop infliximab-induced delayed hypersensitivity reaction and may be an alternative strategy for those at risk...
Novel therapies in the treatment of ulcerative colitisS V Kane
Department of Medicine, Division of Gastroenterology, University of Chicago, 5841 South Maryland Ave, MC 4076, Chicago IL 60637, USA
Expert Opin Investig Drugs 10:1223-9. 2001..This review examines the most recent compounds in development for the treatment of ulcerative colitis, including data from early clinical trials and the potential clinical impact of future entities...
Adherence rates with infliximab therapy in Crohn's diseaseS Kane
Department of Medicine, University of Chicago, Chicago, IL 60637, USA
Aliment Pharmacol Ther 24:1099-103. 2006..Inflammatory bowel disease is associated with non-adherence to treatment with oral medications...
Caring for women with inflammatory bowel diseaseS Kane
Section of Gastroenterology, University of Chicago, 5841 S Maryland Ave, MC 4076, Chicago, IL 60637, USA
J Gend Specif Med 4:54-9. 2001..Health care providers, regardless of their primary focus, should be aware of these differences and should be familiar with certain general information on gender-specific issues, reviewed in this article...
A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitisSunanda Kane
Departments of Medicine and Health Studies, University of Chicago and Illinois Masonic Hospital, Chicago, Illinois 60637, USA
Clin Gastroenterol Hepatol 1:170-3. 2003..This study was conducted to assess, in a small sample, the short-term outcomes of once-daily mesalamine versus conventional dosing in maintaining quiescent ulcerative colitis (UC) and to assess adherence rates with both regimens...
Thalidomide therapy for patients with refractory Crohn's disease: an open-label trialE D Ehrenpreis
Department of Gastroenterology, University of Chicago Hospitals, Chicago, IL 60637, USA
Gastroenterology 117:1271-7. 1999..Inhibition of tumor necrosis factor is a proposed mechanism for the anti-inflammatory properties of thalidomide. We performed an open-label trial of thalidomide in refractory Crohn's disease...
Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flaresP D R Higgins
Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
Aliment Pharmacol Ther 29:247-57. 2009..Ulcerative colitis (UC) can be maintained in remission with 5-aminosalicylic acid (5-ASA) medications, but frequent non-adherence by patients who are feeling well has been associated with more frequent flares of colitis...
Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitisS V Kane
Department of Medicine, University of Chicago, Illinois, USA
Am J Gastroenterol 96:2929-33. 2001..46 [0.39-0.57]). CONCLUSION: Nonadherence is associated with multiple concomitant medications, male gender, and single status. These patient characteristics may be helpful in targeting those patients at higher risk for nonadherence...
Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's diseaseU Mahadevan
Division of Gastroenterology, Department of Medicine, University of California San Francisco, CA 94115, USA
Aliment Pharmacol Ther 21:733-8. 2005..To study the effects of infliximab on pregnancy and foetal outcome...
The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic reviewSunanda V Kane
University of Chicago, Chicago, Illinois, USA
Rev Gastroenterol Disord 3:210-8. 2003..Five-ASA products appear to be as effective as sulfasalazine, but available data do not suggest a difference in efficacy between any of the 5-ASA preparations...
Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomesDeepa Reddy
Division of Gastroenterology, Mount Sinai Medical Center, One Gustave Levy Place, New York, New York, USA
Am J Gastroenterol 103:1203-9. 2008....
The challenge of compliance and persistence: focus on ulcerative colitisSunanda V Kane
Mayo Clinic College of Medicine, Division of Gastroenterology and Hepatology, 200 First Street, SW, 19th Floor, Rochester, MN 55905, USA
J Manag Care Pharm 14:s2-12; quiz s13-5. 2008..An estimated 20% to 50% of patients with ulcerative colitis (UC) do not take their medications as prescribed, resulting in higher disease-recurrence rates and potentially higher health care costs...
Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel diseaseSunanda V Kane
Mayo Clinic, Rochester, Minnesota and University of Chicago, Chicago, Illinois, USA
Am J Gastroenterol 103:1193-6. 2008..The nature of inflammatory bowel disease (IBD) following menopause has not been previously studied. The aim of this study was to characterize the effect of menopause on disease activity and identify possible modifiers of disease activity...
Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC)Themistocles Dassopoulos
Johns Hopkins University Meyerhoff Inflammatory Bowel Disease Center, Baltimore MD, USA
Inflamm Bowel Dis 13:975-83. 2007..Our aim was to determine the reliability and validity of these phenotypic assessments...
Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's diseaseGary R Lichtenstein
University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Inflamm Bowel Dis 10:S2-10. 2004..Here we also evaluate the current preferable treatment practices, based on scientifically valid research and collective clinical experience, for the management of mild to moderate Crohn's disease...
Factitious diarrhea masquerading as refractory celiac diseaseRajesh N Keswani
Section of Gastroenterology, University of Chicago Hospitals, and Department of Internal Medicine, University of Chicago Hospitals, Chicago, IL 60637, USA
South Med J 99:293-5. 2006..This case highlights the importance of considering factitious diarrhea in all patients admitted for refractory diarrhea, even those with documented underlying conditions...
Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease expertsGary R Lichtenstein
University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Inflamm Bowel Dis 10:S11-21. 2004
Novel therapies in the treatment of ulcerative colitisJeffrey A Tuvlin
Department of Medicine, Division of Gastroenterology, University of Chicago, 5841 South Maryland Ave, MC 4076, Chicago, IL 60637, USA
Expert Opin Investig Drugs 12:483-90. 2003..This review examines the most recent compounds in development for the treatment of ulcerative colitis, including data from early clinical trials and the potential clinical impact of future entities...
Crohn's disease involving the gallbladder. case report and review of the literatureCarlos A Rettally
Am J Gastroenterol 98:509-11. 2003
Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypesSteven R Brant
The Harvey M and Lyn P Meyerhoff Inflammatory Bowel Disease Center, Dept of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, U S A
Inflamm Bowel Dis 9:281-9. 2003..Multiple factors, particularly IBD family history, tobacco use, age at diagnosis and recently, NOD2 mutant genotypes may influence Crohn's disease (CD) heterogeneity...
Disease perceptions among people with Crohn's diseaseSunanda V Kane
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Inflamm Bowel Dis 14:1097-101. 2008..We sought to characterize CD patient perceptions of both overall disease course and current symptomatology based on an objective symptom scale and to explore the relationship between perceptions and current symptoms...
Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammationSunanda V Kane
University of Chicago, Chicago, Illinois 60637, USA
Am J Gastroenterol 98:1309-14. 2003..CONCLUSIONS: Fecal lactoferrin is sensitive and specific for detecting inflammation in chronic IBD. This noninvasive test may prove useful in screening for inflammation in patients presenting with abdominal pain and diarrhea...
IBD and PregnancyAudrey H Calderwood
Department of Medicine, University of Chicago, Chicago, Illinois, USA
MedGenMed 6:14. 2004
Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's diseaseMark S Silverberg
Department of Medicine, Mount Sinai Hospital IBD Centre, University of Toronto, Toronto, Ontario, Canada
Eur J Hum Genet 15:328-35. 2007....
Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel diseaseStephanie A Blair
Department of Pathology, The University of Chicago, Chicago, IL 60637, USA
Lab Invest 86:191-201. 2006..Therefore, these data show that MLCK expression and enzymatic activity are increased in IBD. Moreover, the correlation with disease activity suggests that MLCK upregulation may contribute to barrier dysfunction and IBD pathogenesis...
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohortGeoffrey C Nguyen
Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Am J Gastroenterol 101:1012-23. 2006..These findings underscore the need for further studies in minority populations...
